Table of Content

Current Issue

Summer 2021, Vol. 29 No. 2

Hong Kong J. Dermatol. Venereol. (2021) 29, 84-85

Position Statement

Hong Kong College of Dermatologists position statements on COVID-19 vaccination in people with inflammatory skin disease (26 June 2021)

Hong Kong College of Dermatologists

General comments regarding COVID-19 vaccination

*Supplementary information after 26 June 2021: as up to 30 June 2021, there were 4 cases of anaphylaxis, reporting rate = 0.0001% [0.11 cases per 100,000 doses administered] and 2 cases of anaphylactoid reactions, reporting rate = 0.00005% [0.05 cases per 100,000 doses administered] in Hong Kong. We recognize that some people may be at higher risk of COVID-19 associated allergy reactions including those with 1) suspected allergy reaction to prior COVID-19 vaccination (practically means after the first dose); 2) history of anaphylaxis or at risk of anaphylaxis (mere skin rash including urticarial without respiratory distress or circulatory involvement is unlikely to be anaphylaxis); 3) history of severe immediate-type allergy reactions to multiple foods or more than one class of drugs (here refers to severe immediate type allergy reaction, not just erythema or itchiness). In such a circumstance, referral to relevant specialist in immunology and allergy for assessment should be considered.